CLINICAL_TRIALS
trial_result
· 2008-10-17
Clinical Trial Update: Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID) [Phase 3]
Summary
A Phase 3 trial of a pimecrolimus drug-eluting stent for coronary artery disease has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Conor Medsystems | Conditions: Coronary Disease | Phase 3 | Status: TERMINATED